Cargando…

A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS

BACKGROUND: Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs are limited. AIMS: We aimed to estimate indirect...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Matary, W, Witt, J, Bernstein, C N, Jacobson, K, Mack, D R, Otley, A, Walters, T, Huynh, H Q, deBruyn, J, Griffiths, A, Benchimol, E I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859310/
http://dx.doi.org/10.1093/jcag/gwab049.022
_version_ 1784654429151035392
author El-Matary, W
Witt, J
Bernstein, C N
Jacobson, K
Mack, D R
Otley, A
Walters, T
Huynh, H Q
deBruyn, J
Griffiths, A
Benchimol, E I
author_facet El-Matary, W
Witt, J
Bernstein, C N
Jacobson, K
Mack, D R
Otley, A
Walters, T
Huynh, H Q
deBruyn, J
Griffiths, A
Benchimol, E I
author_sort El-Matary, W
collection PubMed
description BACKGROUND: Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs are limited. AIMS: We aimed to estimate indirect and out of pocket (OOP) pediatric IBD-associated costs in Canada. METHODS: In a nation-wide cross-sectional analysis, caregivers of children and young adults (<17 years) with IBD were invited to complete a questionnaire on lost work hours and OOP costs related to IBD in the 4 weeks prior to the survey. Participants were re-invited to periodically answer the same questionnaire every 3–9 months for 2 years. Lost productivity was calculated using the Human Capital method. Costs were reported in 2018 inflation-adjusted Canadian dollars. Predictors of high cost users (top 25%) were examined using negative binomial regression. RESULTS: Consecutive 243 (82 incident cases) of 262 (92.7%) approached participants completed the first survey with a total of 450 surveys longitudinally completed over 2 years. The annual median indirect costs per patient were $5,951 (IQR $1,812- $12,278), with $5,776 (IQR $1,465-$11,733) for Crohn’s disease (CD) and $6,084 (IQR $2,470-$13,371) for ulcerative colitis (UC) (p=0.77). The annual median per patient OOP costs were $2,925 (IQR $978- $8,125) with $3,021 (IQR $978- $8,125) for CD and $2,600 (IQR $975- $8,125) for UC (p=0.55). Older age (10-17y) at diagnosis (p=0.04) and parents in part-time employment (p=0.01) were predictors of higher indirect costs, while female sex (p<0.001), parents with a lower education level (p<0.001) and lower annual family income (p<0.01) were associated with higher OOP costs. CONCLUSIONS: Indirect and OOP IBD-associated costs are substantial and more likely to affect families with unstable employment and lower annual income. Examining different strategies and interventions to reduce these costs such as virtual platforms, telephone and outreach clinics especially in poor communities and families with low annual income is warranted. FUNDING AGENCIES: CIHRThe Children’s Hospital Research Institute of Manitoba
format Online
Article
Text
id pubmed-8859310
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88593102022-02-22 A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS El-Matary, W Witt, J Bernstein, C N Jacobson, K Mack, D R Otley, A Walters, T Huynh, H Q deBruyn, J Griffiths, A Benchimol, E I J Can Assoc Gastroenterol Poster of Distinction BACKGROUND: Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs are limited. AIMS: We aimed to estimate indirect and out of pocket (OOP) pediatric IBD-associated costs in Canada. METHODS: In a nation-wide cross-sectional analysis, caregivers of children and young adults (<17 years) with IBD were invited to complete a questionnaire on lost work hours and OOP costs related to IBD in the 4 weeks prior to the survey. Participants were re-invited to periodically answer the same questionnaire every 3–9 months for 2 years. Lost productivity was calculated using the Human Capital method. Costs were reported in 2018 inflation-adjusted Canadian dollars. Predictors of high cost users (top 25%) were examined using negative binomial regression. RESULTS: Consecutive 243 (82 incident cases) of 262 (92.7%) approached participants completed the first survey with a total of 450 surveys longitudinally completed over 2 years. The annual median indirect costs per patient were $5,951 (IQR $1,812- $12,278), with $5,776 (IQR $1,465-$11,733) for Crohn’s disease (CD) and $6,084 (IQR $2,470-$13,371) for ulcerative colitis (UC) (p=0.77). The annual median per patient OOP costs were $2,925 (IQR $978- $8,125) with $3,021 (IQR $978- $8,125) for CD and $2,600 (IQR $975- $8,125) for UC (p=0.55). Older age (10-17y) at diagnosis (p=0.04) and parents in part-time employment (p=0.01) were predictors of higher indirect costs, while female sex (p<0.001), parents with a lower education level (p<0.001) and lower annual family income (p<0.01) were associated with higher OOP costs. CONCLUSIONS: Indirect and OOP IBD-associated costs are substantial and more likely to affect families with unstable employment and lower annual income. Examining different strategies and interventions to reduce these costs such as virtual platforms, telephone and outreach clinics especially in poor communities and families with low annual income is warranted. FUNDING AGENCIES: CIHRThe Children’s Hospital Research Institute of Manitoba Oxford University Press 2022-02-21 /pmc/articles/PMC8859310/ http://dx.doi.org/10.1093/jcag/gwab049.022 Text en ڣ The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster of Distinction
El-Matary, W
Witt, J
Bernstein, C N
Jacobson, K
Mack, D R
Otley, A
Walters, T
Huynh, H Q
deBruyn, J
Griffiths, A
Benchimol, E I
A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
title A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
title_full A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
title_fullStr A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
title_full_unstemmed A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
title_short A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
title_sort a23 estimating indirect and out-of-pocket costs in pediatric inflammatory bowel disease: a nation-wide cross-sectional analysis
topic Poster of Distinction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859310/
http://dx.doi.org/10.1093/jcag/gwab049.022
work_keys_str_mv AT elmataryw a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT wittj a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT bernsteincn a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT jacobsonk a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT mackdr a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT otleya a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT walterst a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT huynhhq a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT debruynj a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT griffithsa a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis
AT benchimolei a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis